These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2691956)

  • 21. Differential regulation of N-myc and c-myc expression in F9 teratocarcinoma cells.
    Finklestein R; Weinberg RA
    Oncogene Res; 1988; 3(3):287-92. PubMed ID: 3060804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
    Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
    Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
    Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes.
    Vennström B; Bravo R
    Oncogene; 1987; 1(3):271-6. PubMed ID: 3330775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine.
    Cory JG; Cory AH; Long SD; Carter GL; Johnson CE
    Cancer Res; 1992 Apr; 52(7):2000-3. PubMed ID: 1551129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexistence of a c-myc mRNA initiated in intron 1 with the normal c-myc mRNA and similar regulation of both transcripts in mammalian cells.
    Ray D; Robert-Lézénès J
    Oncogene Res; 1989; 5(1):73-8. PubMed ID: 2674860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
    Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S
    Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of c-myc in a transformed cell line approaching stationary phase growth in culture.
    Mulder KM; Levine AE; Hinshaw XH
    Cancer Res; 1989 May; 49(9):2320-6. PubMed ID: 2706619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts.
    Zerlin M; Julius MA; Cerni C; Marcu KB
    Oncogene; 1987 Mar; 1(1):19-27. PubMed ID: 3325875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative regulation of c-myc transcription involves myc family proteins.
    Cleveland JL; Huleihel M; Bressler P; Siebenlist U; Akiyama L; Eisenman RN; Rapp UR
    Oncogene Res; 1988; 3(4):357-75. PubMed ID: 2976141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exogenous c-myc gene overexpression interferes with early events in F9 cell differentiation.
    Onclercq R; Babinet C; Cremisi C
    Oncogene Res; 1989; 4(4):293-302. PubMed ID: 2671866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
    Trojanowska M; Wu LT; LeRoy EC
    Oncogene; 1988 Oct; 3(4):477-81. PubMed ID: 3078955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-myc and c-src genes are differentially regulated in PCC7 embryonal carcinoma cells undergoing neuronal differentiation.
    Sejersen T; Björklund H; Sümegi J; Ringertz NR
    J Cell Physiol; 1986 May; 127(2):274-80. PubMed ID: 3700483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the c-rel and c-myc proto-oncogenes in avian tissues.
    Moore BE; Bose HR
    Oncogene; 1989 Jul; 4(7):845-52. PubMed ID: 2666905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitogenic action of TGF-beta and insulin in L-929 cell line in serum-free medium.
    González-Hernández A; Monreal I; Santiago E; López-Moratalla N
    Rev Esp Fisiol; 1993 Dec; 49(4):249-58. PubMed ID: 7516087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response.
    Rozengurt E; Sinnett-Smith JW
    J Cell Physiol; 1987 May; 131(2):218-25. PubMed ID: 3108267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
    Darling D; Tavassoli M; Linskens MH; Farzaneh F
    Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice.
    Ray R; Thomas S; Miller DM
    Oncogene; 1989 May; 4(5):593-600. PubMed ID: 2657574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.
    Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD
    J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.